UPL Limited (NSE: UPL) has reported its financial results for Q2 and H1 FY27, showcasing profitable growth despite global headwinds. The company’s revenue for the quarter was ₹11,860 crore, down 1% year-on-year, while the half-year revenue stood at ₹22,041 crore, up 4% YoY. The operational PATMI (excluding exceptional items) increased by 33% to ₹441 crore, driven by higher EBITDA and other income.

Q2 Highlights

The second quarter of FY27 saw revenue broadly flat YoY, with favorable FX tailwinds offsetting a decline in global crop protection volumes. However, the platform segments showed robust growth: Specialty Chemicals grew by 50%, and Seeds and Post harvest by 12%. Regions like North America and Rest of the World (RoW) contributed significantly with growth rates of 19% each.

H1 Highlights

For the first half of FY27, revenue increased by 4% to ₹22,041 crore, led by strong performances from Advanta and SUPERFORM. The company’s contribution and EBITDA margins expanded by 140 bps and 80 bps respectively, resulting in 7% and 9% absolute growth. The operational PATMI for the half-year was ₹441 crore, up 33% from the previous year, primarily due to higher EBITDA and other income.

Jai Shroff, Chairman & Group CEO of UPL Limited, remarked, ‘Our results this quarter reflect the strength of the diversified model we have built. Despite a volatile global backdrop, our businesses continued to execute with discipline; Advanta and SUPERFORM delivered strong growth, while our crop protection businesses navigated phased demand and challenging weather. With rising commodity prices potentially setting the stage for better farm economics, we remain focused on building a stronger and future-ready UPL, and on creating long-term value for all our stakeholders.’ Bikash Prasad, Group CFO, added, ‘Our first half performance underscores the resilience of UPL’s earnings in a challenging environment. Eight consecutive quarters of margins and EBITDA growth reflect our continued focus on quality of earnings, sharper portfolio decisions, and firm cost and capital discipline. These choices have allowed us to protect margins despite continued global headwinds. Our capital priorities are unchanged: converting earnings into cash, deleveraging, and improving returns. Proactive refinancing and improved outlooks from S&P and CRISIL reflect a balance sheet that is getting stronger.’

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of UPL Limited

UPL Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.

UPL falls 13.3% over three months and has not found a floor yet. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. Revenue contracts at -1.2% CAGR. That signals structural headwinds, not a short-term blip. The stock sits at 17% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at -1.2% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of UPL Limited.

Dhanuka Agritech Limited (DHANUKA) has reported a significant improvement in its second-quarter profitability for FY27, with its Profit After Tax (PAT) growing 16.23% year-on-year to ₹109.22 crore. Revenue from operations for the quarter increased 9.91% to ₹657.51 crore, against ₹598.25 crore in Q2 FY26. This profit growth outpaces revenue growth as the agrochemical major reports improved profitability in Q2 FY27.

Financial Highlights

The financial performance of Dhanuka Agritech in Q2 FY27 was marked by several key metrics:

Revenue from Operations: ₹657.51 crore (Up 9.91%)

Gross Profit: ₹270.77 crore (Up 6.62%)

Gross Profit Margin: 41.18% (compared to 42.45% in Q2 FY26)

EBITDA: ₹152.97 crore (Up 11.88%)

Profit Before Tax (PBT): ₹146.47 crore (Up 16.27%)

Profit After Tax (PAT): ₹109.22 crore (Up 16.23%)

Management Commentary

Commenting on the performance, Mr. Rahul Dhanuka, Managing Director, Dhanuka Agritech Limited said: “Our Q2 profitability expansion was supported by healthy channel inventory liquidation and steady demand during the autumn farming cycle. We remain focused on building a sustainable and innovation-led growth platform for Dhanuka Agritech. The Indian agricultural sector continues to present significant opportunities, particularly in the areas of crop productivity, advanced crop protection solutions and the adoption of innovative agricultural technologies. Our focus remains on strengthening our product portfolio, deepening farmer engagement, and expanding our market presence. We believe that continued investment in innovation and farmer-centric solutions will remain central to our long-term growth journey.”

The unaudited financial results for the quarter and half year ended September 30, 2026, were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on October 30, 2026.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Dhanuka Agritech Limited

Dhanuka Agritech Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.

Dhanuka falls 14.6% over three months and has not found a floor yet. The PEG of 2.06 makes it expensive versus peers. The premium needs earnings to catch up quickly. No meaningful dividend — total return is entirely dependent on capital appreciation. RSI stands at 31, well into oversold territory. Yet sellers still dominated on 15 of recent sessions versus 15 for buyers, so the pressure has not fully lifted. Revenue grows at 5.1% CAGR — a respectable pace. However, the stock drops 14.6% in three months without an obvious fundamental trigger. Sector-wide pressure or a valuation re-rating can persist for longer than expected. Therefore, there is no rush to step in. Check Fundamentals of Dhanuka Agritech Limited.

Sharda Cropchem Limited (SHARDACROP) has unveiled its investor presentation for October 2026, highlighting a steady, strong, and growing trajectory for the company. The presentation underscores the company’s commitment to advancing global agriculture through an IP-led growth platform.

Advancing Global Agriculture

SHARDACROP is a leading intellectual property-driven agrochemical company engaged in the marketing and distribution of crop protection formulations and generic active ingredients. The company’s strategy focuses on leveraging a growing portfolio of dossiers, registrations, and intellectual property rights to build a differentiated platform for sustainable growth across regulated global markets.

Asset-Light, Registration-Led Business Model

The company’s core capabilities include basic and applied research, product identification, product registration, active ingredient manufacturing, formulation, and marketing distribution. By partnering with specialized manufacturers for manufacturing-related activities, SHARDACROP remains capital efficient, operationally agile, and well positioned to scale across geographies and product categories.

Global Market Reach

Supported by a network of over 525 distributors and 500 sales professionals, SHARDACROP serves customers across more than 80 countries. This extensive global presence not only expands the company’s market reach but also enables access to specialized sales and local marketing talent across key agricultural regions.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Sharda Cropchem Limited

Sharda Cropchem Limited belongs to the Basic Materials › Agricultural Inputs sector. Here’s a quick read on where the business and the stock stand today.

Sharda drops 19.3% over three months and trades near its 52-week lows. The PEG of 0.41 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Revenue and profit grow at 9.2% and 25.8% CAGR respectively. The pace is steady, and stability drives the investment case. The stock sits at 5% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. The business compounds at 9.2% revenue and 25.8% profit CAGR, with D/E of 0.00. Yet the stock drops 19.3% in three months. The business does not deteriorate — the stock does. That gap is what long-term investors look for. Check Fundamentals of Sharda Cropchem Limited.